Xeris is an Illinois-based biopharmaceutical company that develops and commercializes liquid-stable injectables for the treatment of diabetes and epilepsy... Read more
Xeris is an Illinois-based biopharmaceutical company that develops and commercializes liquid-stable injectables for the treatment of diabetes and epilepsy... Read more
News
Mar 11, 2026
Seeking Alpha
Xeris Biopharma: Xeris Biopharma Holdings, Inc. (XERS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Mar 04, 2026
Seeking Alpha
Xeris Biopharma: Xeris Biopharma: Undervalued Given The Potential Of Its Drug Portfolio
Mar 03, 2026
Owler
Xeris Biopharma Holdings, Inc.: Xeris Biopharma's revenue changed from $266.14M in Sep 2025 to $291.85M in Dec 2025
Mar 02, 2026
Marketscreener
Xeris Biopharma: Xeris Biopharma Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025
Mar 02, 2026
Seeking Alpha
Xeris Biopharma: Xeris Pharmaceuticals GAAP EPS of $0.06 beats by $0.03, revenue of $85.81M misses by $0.19M
Mar 02, 2026
RTTNews
Xeris Biopharma: Xeris Biopharma Delivers 44% FY25 Revenue Growth, Stock Up
Feb 27, 2026
Investing.com
Xeris Biopharma: Xeris Pharmaceuticals faces earnings test as growth accelerates
Feb 27, 2026
Benzinga
Xeris Biopharma: Why Are Shares Of Xeris Biopharma Falling Friday?
Feb 26, 2026
Benzinga
Xeris Biopharma: Xeris Biopharma Subsidiaries File Recorlev Patent Infringement Lawsuit
Feb 19, 2026
Nasdaq
Xeris Biopharma: XERS Crosses Below Key Moving Average Level
Xeris Biopharma Competitors
1
2
3
4
5
6
7
8
9
10